Heidi M. Mansour

Inhalable Dry Powders of Antimicrobial Agents in Respiratory Diseases

Background Respiratory infections remain a major global health burden despite advances in systemic antimicrobial therapy. Antimicrobial dry powder inhalers (DPIs) have emerged as precision-engineered pulmonary delivery platforms capable of achieving high local drug concentrations...